Lbp Am Sa Invests $3.90 Million in Elevance Health, Inc. $ELV

Lbp Am Sa acquired a new stake in shares of Elevance Health, Inc. (NYSE:ELV) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 12,061 shares of the company’s stock, valued at approximately $3,897,000.

A number of other institutional investors have also recently made changes to their positions in ELV. Vanguard Group Inc. boosted its holdings in shares of Elevance Health by 3.2% in the second quarter. Vanguard Group Inc. now owns 22,856,898 shares of the company’s stock worth $8,890,419,000 after buying an additional 704,790 shares during the last quarter. Sanders Capital LLC increased its position in shares of Elevance Health by 24.7% during the 2nd quarter. Sanders Capital LLC now owns 5,825,208 shares of the company’s stock valued at $2,265,773,000 after purchasing an additional 1,152,440 shares during the last quarter. Artisan Partners Limited Partnership lifted its stake in shares of Elevance Health by 9.7% during the 2nd quarter. Artisan Partners Limited Partnership now owns 3,675,179 shares of the company’s stock worth $1,429,498,000 after acquiring an additional 324,399 shares during the last quarter. Norges Bank bought a new position in Elevance Health in the 2nd quarter worth about $1,148,379,000. Finally, Massachusetts Financial Services Co. MA increased its position in Elevance Health by 4.8% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,440,630 shares of the company’s stock valued at $788,616,000 after purchasing an additional 112,020 shares during the period. Hedge funds and other institutional investors own 89.24% of the company’s stock.

Elevance Health Stock Down 14.4%

Elevance Health stock opened at $322.55 on Wednesday. The company has a 50-day simple moving average of $350.06 and a 200-day simple moving average of $328.78. The company has a debt-to-equity ratio of 0.71, a quick ratio of 1.56 and a current ratio of 1.56. The firm has a market capitalization of $71.68 billion, a P/E ratio of 13.19, a P/E/G ratio of 1.94 and a beta of 0.51. Elevance Health, Inc. has a one year low of $273.71 and a one year high of $458.75.

Elevance Health (NYSE:ELV) last released its earnings results on Wednesday, January 28th. The company reported $3.33 EPS for the quarter, topping analysts’ consensus estimates of $3.07 by $0.26. The business had revenue of $49.31 billion for the quarter, compared to the consensus estimate of $49.52 billion. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, equities analysts expect that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Zacks Research raised shares of Elevance Health from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. Mizuho set a $413.00 target price on shares of Elevance Health in a research note on Friday, January 9th. Weiss Ratings raised Elevance Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, January 12th. Barclays upped their price objective on Elevance Health from $385.00 to $404.00 and gave the stock an “overweight” rating in a research report on Monday, January 5th. Finally, The Goldman Sachs Group began coverage on shares of Elevance Health in a research note on Tuesday, October 14th. They set a “neutral” rating and a $343.00 target price for the company. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Elevance Health has a consensus rating of “Moderate Buy” and an average target price of $399.63.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.